# Elena Zamagni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elena-zamagni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,081 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 67 |
| i10-index | 176 |
| Last Known Institution | Istituto di Ematologia di Bologna |
| OpenAlex ID | https://openalex.org/A5055543156 |
| ORCID iD | https://orcid.org/0000-0003-1422-7305 |
| Works | 466 |

## Researcher papers

- [International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma](https://scholariq.org/papers/international-myeloma-working-group-consensus-criteria-for-response-and-minimal/)
- [A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial](https://scholariq.org/papers/a-simplified-frailty-scale-predicts-outcomes-in-transplant-ineligible-patients/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

## Researcher university

- [Istituto di Ematologia di Bologna](https://scholariq.org/institutions/istituto-di-ematologia-di-bologna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.